Organometallic 99mTc-technetium(I)- and Re-rhenium(I)-folate derivatives for potential use in nuclear medicine

Journal of Organometallic Chemistry

Volumn 689, Issue 25 SPEC. ISS., 2004, Pages 4712-4721

  Müller, Cristina ^a   Dumas, Cécile ^a   Hoffmann, Ute ^a   Schubiger, P August ^a,b   Schibli, Roger ^a,b  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Folate radiopharmaceutical; Folate receptor; Folic acid derivatives; Rhenium(I); Technetium(I)

Indexed keywords

ACETIC ACID; CELLS; CHELATION; CHEMICAL MODIFICATION; DERIVATIVES; DIAGNOSIS; DRUG PRODUCTS; ISOTOPES; PROTEINS; RHENIUM COMPOUNDS; TECHNETIUM COMPOUNDS; TUMORS;

CELL BINDING; FOLATE RECEPTORS (FR); FOLIC ACID; PTEROIC ACID;

ORGANOMETALLICS;

FOLIC ACID DERIVATIVE; ORGANOMETALLIC COMPOUND; RHENIUM 188; TECHNETIUM 99M;

BINDING AFFINITY; CHELATION; CHEMICAL REACTION; COMPLEX FORMATION; CONFERENCE PAPER; DRUG PROTEIN BINDING; DRUG USE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MEDICINE; QUANTUM YIELD;

EID: 11844282187     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2004.08.045     Document Type: Conference Paper

References (45)

1. C.P. Leamon, and P.S. Low Proc. Natl. Acad. Sci. USA 88 1991 5572
2. C.P. Leamon, and P.S. Low Biochem. J. 291 1993 855
3. A.C. Antony Blood 79 1992 2807
4. A.C. Antony Annu. Rev. Nutr. 16 1996 501
5. S.D. Weitman, R.H. Lark, L.R. Coney, D.W. Fort, V. Frasca, V.R. Zurawski, and B.A. Kamen Cancer Res. 52 1992 3396
6. G. Toffoli, C. Cernigoi, A. Russo, A. Gallo, M. Bagnoli, and M. Boiocchi Int. J. Cancer 74 1997 193
7. J. Sudimack, and R.J. Lee Adv. Drug Deliv. Rev. 41 2000 147
8. C.P. Leamon, and P.S. Low Drug Discov. Today 6 2001 44
9. C.Y. Ke, C.J. Mathias, and M.A. Green Nucl. Med. Biol. 30 2003 811
10. W.J. Guo, G.H. Hinkle, and R.J. Lee J. Nucl. Med. 40 1999 1563
11. C.A. Ladino, R.V.J. Chari, L.A. Bourret, N.L. Kedersha, and V.S. Goldmacher Int. J. Cancer 73 1997 859
12. J.W. Lee, J.Y. Lu, P.S. Low, and P.L. Fuchs Bioorg. Med. Chem. 10 2002 2397
13. J. Matulic-Adamic, M. Sanseverino, and L. Beigelman Tetrahedron Lett. 43 2002 4439
14. C.P. Leamon, S.R. Cooper, and G.E. Hardee Bioconjugate Chem. 14 2003 738
15. C.P. Leamon, I. Pastan, and P.S. Low J. Biol. Chem. 268 1993 24847
16. J.Y. Lu, D.A. Lowe, M.D. Kennedy, and P.S. Low J. Drug Target. 7 1999 43
17. C.M. Ward, N. Acheson, and L.W. Seymour J. Drug Target. 8 2000 119
18. D.M. Kranz, T.A. Patrick, K.E. Brigle, M.J. Spinella, and E.J. Roy Proc. Natl. Acad. Sci. USA 92 1995 9057
19. B.K. Cho, E.J. Roy, T.A. Patrick, and D.M. Kranz Bioconjugate Chem. 8 1997 338
20. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, F. Mandelbaum-Shavit, M.M. Qazen, and S. Zalipsky Bioconjugate Chem. 10 1999 289
21. W.J. Guo, T. Lee, J. Sudimack, and R.J. Lee J. Liposome Res. 10 2000 179
22. G.F. Shi, W.J. Guo, S.M. Stephenson, and R.J. Lee J. Control. Release 80 2002 309
23. C.P. Leamon, D. Weigl, and R.W. Hendren Bioconjugate Chem. 10 1999 947
24. J.A. Reddy, and P.S. Low J. Control. Release 64 2000 27
25. H.E.J. Hofland, C. Masson, S. Iginla, I. Osetinsky, J.A. Reddy, C.P. Leamon, D. Scherman, M. Bessodes, and P. Wils Mol. Ther. 5 2002 739
26. S. Ilgan, D.J. Yang, T. Higuchi, F. Zareneyrizi, H. Bayhan, D.F. Yu, E.E. Kim, and D.A. Podoloff Cancer Biother. Radiopharm. 13 1998 427
27. C.J. Mathias, D. Hubers, P.S. Low, and M.A. Green Bioconjugate Chem. 11 2000 253
28. C.P. Leamon, M.A. Parker, I.R. Vlahov, L.C. Xu, J.A. Reddy, M. Vetzel, and N. Douglas Bioconjugate Chem. 13 2002 1200
29. C.J. Mathias, S. Wang, D.J. Waters, J.J. Turek, P.S. Low, and M.A. Green J. Nucl. Med. 39 1998 1579
30. C.J. Mathias, and M.A. Green Nucl. Med. Biol. 25 1998 585
31. B.A. Siegel, F. Dehdashti, D.G. Mutch, D.A. Podoloff, R. Wendt, G.P. Sutton, R.W. Burt, P.R. Ellis, C.J. Mathias, M.A. Green, and D.M. Gershenson J. Nucl. Med. 44 2003 700
32. R. Alberto, R. Schibli, A. Egli, P.A. Schubiger, W.A. Herrmann, G. Artus, U. Abram, and T.A. Kaden J. Organomet. Chem. 492 1995 217
33. R. Alberto, R. Schibli, A. Egli, A.P. Schubiger, U. Abram, and T.A. Kaden J. Am. Chem. Soc. 120 1998 7987
34. R. Alberto, R. Schibli, R. Waibel, U. Abram, and A.P. Schubiger Coord. Chem. Rev. 192 1999 901
35. R. Schibli, and P.A. Schubiger Eur. J. Nucl. Med. Mol. Imaging 29 2002 1529
36. D.P. Trump, C.J. Mathias, Z.F. Yang, P.S. Low, M.E. Marmion, and M.A. Green J. Nucl. Med. 41 2000 1014
37. D.P. Trump, C.J. Mathias, Z.F. Yang, P.S.W. Low, M. Marmion, and M.A. Green Nucl. Med. Biol. 29 2002 569
38. R. Alberto, K. Ortner, N. Wheatley, R. Schibli, and A.P. Schubiger J. Am. Chem. Soc. 123 2001 3135
39. J.F. Pons, J.L. Fauchere, F. Lamaty, A. Molla, and R. Lazaro Eur. J. Org. Chem. 1998 853
40. A. Stichelberger, R. Waibel, C. Dumas, P.A. Schubiger, and R. Schibli Nucl. Med. Biol. 30 2003 465
41. C.P. Leamon, R.B. DePrince, and R.W. Hendren J. Drug Target. 7 1999 157
42. C.Y. Ke, C.J. Mathias, and M.A. Green J. Nucl. Med. 42 2001 427
43. S. Wang, J. Luo, D.A. Lantrip, D.J. Waters, C.J. Mathias, M.A. Green, P.L. Fuchs, and P.S. Low Bioconjugate Chem. 8 1997 673
44. M. Nomura, S. Shuto, and A. Matsuda J. Org. Chem. 65 2000 5016
45. A. Egli, K. Hegetschweiler, R. Alberto, U. Abram, R. Schibli, R. Hedinger, V. Gramlich, R. Kissner, and P.A. Schubiger Organometallics 16 1997 1833